These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 8229487

  • 1. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
    Horbar JD, Wright LL, Soll RF, Wright EC, Fanaroff AA, Korones SB, Shankaran S, Oh W, Fletcher BD, Bauer CR.
    J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [Abstract] [Full Text] [Related]

  • 3. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL, Kimberlin LV, Auten RL, Rosenberg AA, Asselin JM, Belcastro MR, Donohue PK, Hamm CR, Jansen RD, Brody AS, Riddlesberger MM, Montgomery P.
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [Abstract] [Full Text] [Related]

  • 4. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    da Costa DE, Pai MG, Al Khusaiby SM.
    Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML, Farrell EE, Rosenberg AA, Jung AL, Auten RL, Durand DJ, Horgan MJ, Buckwald S, Belcastro MR, Donohue PK, Carrion V, Maniscalco WW, Balsan MJ, Torres BA, Miller RR, Jansen RD, Graeber JE, Laskay KM, Matteson EJ, Egan EA, Brody AS, Martin DJ, Riddlesberger MM, Montgomery P.
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [Abstract] [Full Text] [Related]

  • 7. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS, Ewing CK, Richards T, Taeusch HW.
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
    Hamdan AH, Shaw NJ.
    Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
    Bose C, Corbet A, Bose G, Garcia-Prats J, Lombardy L, Wold D, Donlon D, Long W.
    J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
    Smyth J, Allen A, MacMurray B, Peliowski A, Sankaran K, Volberg F, Shukla A, Long W.
    J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
    [Abstract] [Full Text] [Related]

  • 16. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL, Faulds D.
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [Abstract] [Full Text] [Related]

  • 17. Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
    Lloyd J, Todd DA, John E.
    Early Hum Dev; 1999 Mar; 54(2):157-68. PubMed ID: 10213294
    [Abstract] [Full Text] [Related]

  • 18. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL.
    Biol Neonate; 1995 Mar; 67 Suppl 1():32-47. PubMed ID: 7647157
    [Abstract] [Full Text] [Related]

  • 19. [Use of Exosurf Neonatal, a synthetic surfactant, in the treatment of respiratory distress syndrome in the newborn].
    Mikhel'sonVA, Grebennikov VA, Belaĭ VA, Everstova TN.
    Anesteziol Reanimatol; 1995 Mar; (1):4-7. PubMed ID: 7605034
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.